Technical Analysis for LBPH - Longboard Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 21.38 | -6.29% | -1.44 |
LBPH closed down 6.29 percent on Friday, May 3, 2024, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: May 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bearish Engulfing | Bearish | 0.00% | |
| Stochastic Sell Signal | Bearish | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | -6.29% | |
| Wide Bands | Range Expansion | -6.29% |
| Alert | Time |
|---|---|
| Outside Day | 2 days ago |
| Down 5% | 2 days ago |
| Fell Below Previous Day's Low | 2 days ago |
| Down 1 ATR | 2 days ago |
| Down 3% | 2 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. The company was founded in 2020 and is based in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Neuroscience Epilepsy Psychiatry Amyotrophic Lateral Sclerosis Neurophysiology Neurology Nervous System Clinical Trial Product Neurological Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Neuroscience Epilepsy Psychiatry Amyotrophic Lateral Sclerosis Neurophysiology Neurology Nervous System Clinical Trial Product Neurological Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 28.15 |
| 52 Week Low | 3.6 |
| Average Volume | 460,126 |
| 200-Day Moving Average | 12.26 |
| 50-Day Moving Average | 20.10 |
| 20-Day Moving Average | 19.50 |
| 10-Day Moving Average | 20.63 |
| Average True Range | 1.51 |
| RSI (14) | 56.33 |
| ADX | 15.19 |
| +DI | 29.28 |
| -DI | 14.83 |
| Chandelier Exit (Long, 3 ATRs) | 19.43 |
| Chandelier Exit (Short, 3 ATRs) | 21.08 |
| Upper Bollinger Bands | 22.63 |
| Lower Bollinger Band | 16.37 |
| Percent B (%b) | 0.8 |
| BandWidth | 32.12 |
| MACD Line | 0.57 |
| MACD Signal Line | 0.14 |
| MACD Histogram | 0.4294 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 25.70 | ||||
| Resistance 3 (R3) | 26.08 | 25.02 | 24.98 | ||
| Resistance 2 (R2) | 25.02 | 23.92 | 24.83 | 24.74 | |
| Resistance 1 (R1) | 23.20 | 23.24 | 22.67 | 22.82 | 24.50 |
| Pivot Point | 22.13 | 22.13 | 21.87 | 21.94 | 22.13 |
| Support 1 (S1) | 20.31 | 21.03 | 19.78 | 19.93 | 18.25 |
| Support 2 (S2) | 19.25 | 20.35 | 19.06 | 18.01 | |
| Support 3 (S3) | 17.43 | 19.25 | 17.77 | ||
| Support 4 (S4) | 17.05 |
